FASLG and systemic lupus erythematosus: Previous studies on SLE patients revealed enhanced apoptosis rate without any abnormalities in apoptosis machinery (7, 8), but most of these investigations have been performed at protein level, by detecting Annexin V as an early marker for apoptosis (9), or by detecting Fas (CD95) and/or FasL expression using flow cytometry.